• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

AM211 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758544

AM211 is a potent and orally bioavailable antagonist of prostaglandin D2 (PGD2) receptor type 2 (DP2) More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
AM211, Inhibitor
Full Product Name
AM211
Product Gene Name
Product Synonym Names
AM211 free acid
Form/Format
Solid. Powder
Purity/Purification
98.28%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
500.51
Solubility
DMSO: 125mg/mL (249.75mM)
Ethanol: 85mg/mL (185.6mM)
Water: <1mg/mL
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C27H27F3N2O4
SMILES
CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1
CAS Number
1175526-27-8
Target & IC50
Akt1: ic50 5nM
Akt2: ic50 18nM
Akt3: ic50 8nM
Human DP2: ic50 4.9nM
Mouse DP2: ic50 7.8nM
Guinea pig DP2: ic50 4.9nM
Rat DP2: ic50 10.4nM
prostaglandin D2 receptor
Cell Research
GDC-0068 is prepared in DMSO and stored, and then diluted with appropriate medium before use[2]. The 384-well plates are seeded with 2,000 cells per well in a volume of 54 uL per well followed by incubation at 37 degree C under 5% CO2 overnight (~16 hours). Compounds (e.g., GDC-0068) are diluted in DMSO to generate the desired stock concentrations then added in a volume of 6 uL per well. All treatment, are tested in quadruplicates. After 4 days incubation, relative numbers of viable cells are estimated using CellTiter-Glo and total luminescence is measured on a Wallac Multilabel Reader. The concentration of drug resulting in IC50 is calculated from a 4-parameter curve analysis (XLfit) and is determined from a minimum of 3 experiments. For cell lines that failed to achieve an IC50, the highest concentration tested (10uM) is listed[2].
In Vitro
AM211 exhibits good oral bioavailability in rats and dogs and dose-dependently inhibits 13,14-dihydro-15-keto-PGD(2)-induced leukocytosis in a guinea pig pharmacodynamic assay. AM211 demonstrates efficacy in two animal models of allergic inflammation, including an ovalbumin-induced lung inflammation model in guinea pigs and an ovalbumin-induced mouse model of allergic rhinitis. AM211 represents a potent and selective antagonist of DP2 that may be used clinically to evaluate the role of DP2 in T helper 2-driven allergic inflammatory diseases[1].

Structure of AM211, inhibitor

AM211 Inhibitor – Cat# MBS5758544

Product References and Citations for AM211, inhibitor

Lin K. Cancer Res, 2011, 71(8 Supplement), abstract DDT02-01.
Bain G, Lorrain D S, Stebbins K J, et al. Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation[J]. Journal of Pharmacology and Experimental Therapeutics, 2011, 338(1):290-301.
Bain G, Lorrain D S, Stebbins K J, et al. Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation[J]. Journal of Pharmacology and Experimental Therapeutics, 2011, 338(1):290-301.
James F. Blake. 2011.
Bain G, King C D, Brittain J, et al. Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2[J]. The Journal of Clinical Pharmacology, 2012, 52(10).
Bain G, King C D, Brittain J, et al. Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2[J]. The Journal of Clinical Pharmacology, 2012, 52(10).
Tabernero J, et al. Ann Oncol, 2011, 22(suppl 3), abstract IL33.
Heidi M. Savage, et al. Cancer Res, 2012, 72(8 Supplement), 966.
Roel Funke, et al. American Society of Clinical Oncology (ASCO) Annual Meeting, 1-5, 2012.

Other Notes

Small volumes of AM211, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for AM211 purchase

MBS5758544 is an inhibitor targeting AM211.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000